Antiretroviral coverage lacking in 30 percent of ADAPs














The AIDS Drug Assistance Program (ADAP) has become a critical source of prescription drugs for low-income people with HIV/AIDS who have no or limited prescription drug coverage. There are 57 ADAPs, yet nearly 30 percent do not include coverage of all FDA-approved antiretroviral (ARV) therapies on their formularies, and South Dakota does not provide any protease inhibitor (PI) coverage at all, according to the annual report of the National ADAP Monitoring Project.

Forty-two ADAPs cover enfuvirtide (Fuzeon), a recently approved fusion inhibitor. Fuzeon interferes with the entry of HIV-1 into cells by inhibiting the fusion of viral and cellular membranes. This is up from 33 ADAPs reported last year. ADAPs in Alaska, Hawaii, Idaho, Kentucky, Nebraska, New Mexico, North Dakota, South Dakota, West Virginia, and Wyoming do not extend formulary coverage to enfuvirtide.

State ADAP formulary coverage of approved antiretroviral drugs under the AIDS Drug Assistance Program

Note: 2004 data; no information for American Samoa, Guam, the Northern Mariana Islands, Marshall Islands, and the U.S. Virgin Islands.

NRTI: nucleoside reverse transcriptase inhibitor

NNRTI: non-nucleoside reverse transcriptase inhibitor

Source: National ADAP Monitoring Project. Annual Report.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.

UP NEXT

Managed Care
By Peter Wehrwein
Managed Care
By Howard Wolinsky